Hexagon Capital Partners’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-216
Closed -$7.55K – 1308
2025
Q1
$7.55K Sell
216
-292
-57% -$11.9K ﹤0.01% 1056
2024
Q4
$22.6K Buy
508
+211
+71% +$8.63K ﹤0.01% 745
2024
Q3
$13.5K Buy
297
+115
+63% +$4.65K ﹤0.01% 827
2024
Q2
$6.05K Buy
182
+9
+5% +$368 ﹤0.01% 980
2024
Q1
$8.29K Buy
+173
New +$10.1K ﹤0.01% 896
2023
Q1
– Sell
-17
Closed -$1.46K – 1496
2022
Q4
$1.46K Hold
17
– – ﹤0.01% 1144
2022
Q3
$1K Sell
17
-28
-62% -$2.5K ﹤0.01% 1243
2022
Q2
$4K Buy
45
+42
+1,400% +$4.28K ﹤0.01% 855
2022
Q1
$0 Buy
+3
New +$320 ﹤0.01% 970

Other funds holding QDEL

Hexagon Capital Partners's QDEL Position: Q2 2025 in Review

Hexagon Capital Partners sold out of QuidelOrtho (QDEL) in Q2 2025, closing a stake of 216 shares — an estimated $7.55K sold.

Hexagon Capital Partners first reported a position in QDEL in Q1 2022 and held it in 9 quarters. The position peaked at $22.6K in Q4 2024. 264 funds tracked by Wall St. Rank hold QDEL as of Q2 2025.

  • Hexagon Capital Partners reported no remaining QuidelOrtho position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 216 QuidelOrtho shares in Q2 2025, an estimated $7.55K.
  • Hexagon Capital Partners first reported a position in QuidelOrtho in Q1 2022 and held it in 9 quarters.
  • Hexagon Capital Partners's QuidelOrtho position peaked at $22.6K in Q4 2024.
  • 264 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.